McKesson May Acquire Option Care Health
The potential multibillion-dollar deal for the infusion services provider could be announced as early as Tuesday.
Updated on Oct. 5, 2026 in Healthcare
Live Poll
Should private equity firms be allowed to acquire large-scale healthcare service providers?
McKesson and private equity firm Clayton Dubilier & Rice are in negotiations to acquire Option Care Health. The proposed acquisition is valued at more than $5 billion, including debt.
Why it matters
The acquisition would signal a significant consolidation in the outpatient infusion services market. It reflects a growing industry interest in shifting intravenous medication delivery from traditional hospital settings to patient homes or clinics.
The potential deal is valued at over $5 billion, an amount that accounts for the inclusion of existing debt. Whether the parties reach a final agreement or if the current talks collapse remains unknown.
The players
McKesson
McKesson is a major American corporation that specializes in the distribution of pharmaceuticals and medical supplies.
Clayton Dubilier & Rice
Clayton Dubilier & Rice is a prominent private equity investment firm based in the United States.
Option Care Health
Option Care Health is a leading national provider of home and alternate-site infusion services.
The details
Option Care Health specializes in the provision of infusion services for intravenous medications in outpatient and home-based settings. Should the acquisition proceed, it would integrate the company's clinical infusion network with the broader supply chain capabilities of McKesson and its partners.
Timeline
Negotiations were reported on October 5, 2026.
A potential announcement regarding the deal is expected by October 6, 2026.
Market Landscape
This move aligns with the broader industry trend of site-of-care optimization, where healthcare players increasingly prioritize shifting intravenous treatments away from high-cost hospital environments. It positions the combined entities to better control the end-to-end delivery of complex home-infusion care.
Patients currently utilizing Option Care Health services are unlikely to see immediate disruptions while the companies continue to negotiate. Any eventual change in ownership may later impact how insurance coverage and service providers are coordinated for home-based infusions.
The takeaway
Healthcare consolidation is increasingly focusing on specialized care delivery outside of traditional hospital walls. Consumers should monitor their current infusion provider's network status for any changes to service coverage if the deal is finalized.
Further reading
Learn more about the latest industry trends in the Healthcare sector.
Live Poll
Should private equity firms be allowed to acquire large-scale healthcare service providers?
